Cargando…
Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697048/ http://dx.doi.org/10.1177/20406223231215701 |
| _version_ | 1785154700686917632 |
|---|---|
| author | Jin, Shenhe Liu, Yi Zhang, Ye Zhou, Fengping You, Liangshun Zhang, Jin |
| author_facet | Jin, Shenhe Liu, Yi Zhang, Ye Zhou, Fengping You, Liangshun Zhang, Jin |
| author_sort | Jin, Shenhe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10697048 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106970482023-12-06 Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting Jin, Shenhe Liu, Yi Zhang, Ye Zhou, Fengping You, Liangshun Zhang, Jin Ther Adv Chronic Dis Letter to the Editor SAGE Publications 2023-12-04 /pmc/articles/PMC10697048/ http://dx.doi.org/10.1177/20406223231215701 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Jin, Shenhe Liu, Yi Zhang, Ye Zhou, Fengping You, Liangshun Zhang, Jin Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting |
| title | Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting |
| title_full | Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting |
| title_fullStr | Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting |
| title_full_unstemmed | Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting |
| title_short | Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting |
| title_sort | bispecific t cell engagers targeting cd20/cd3 in b-cell lymphoma: latest updates from 2023 eha annual meeting |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697048/ http://dx.doi.org/10.1177/20406223231215701 |
| work_keys_str_mv | AT jinshenhe bispecifictcellengagerstargetingcd20cd3inbcelllymphomalatestupdatesfrom2023ehaannualmeeting AT liuyi bispecifictcellengagerstargetingcd20cd3inbcelllymphomalatestupdatesfrom2023ehaannualmeeting AT zhangye bispecifictcellengagerstargetingcd20cd3inbcelllymphomalatestupdatesfrom2023ehaannualmeeting AT zhoufengping bispecifictcellengagerstargetingcd20cd3inbcelllymphomalatestupdatesfrom2023ehaannualmeeting AT youliangshun bispecifictcellengagerstargetingcd20cd3inbcelllymphomalatestupdatesfrom2023ehaannualmeeting AT zhangjin bispecifictcellengagerstargetingcd20cd3inbcelllymphomalatestupdatesfrom2023ehaannualmeeting |